ZeroStack Corp. logo

ZeroStack Corp.

ZSTK

NASDAQFinancial ServicesAsset Management

Previous close

$4.71

−$1.18 · -20.03%

Aug 21, 4:00 PM ET

ZSTK company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

31

Expensive

Momentum

23

Weakening

Sentiment

43

Mixed

Risk resilience

18

Extreme Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.

Industry
Asset Management
Sector
Financial Services
Headquarters
CA
CEO
Daniel Reis-Faria
Listed since
May 11, 2021
Employees
21

Market position

Day range

Current $4.71

52-week range

Current $4.71

Open
$5.74
Previous close
$5.89
Volume
463.87K
1.52× average
Average volume
306.13K
Average daily volume
Market cap
4.93M USD
Beta
1.71
Market reference 1
50-day average
$10.2335
-53.97% below average
200-day average
$10.2335
-53.97% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
65.54M USD
P/E (TTM)
-0.04×
P/B (TTM)
3.4×
P/S (TTM)
0.12×
EV / EBITDA
-7.3×
Earnings yield
-701.24%
Free cash flow yield
-51.08%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
-9.78%
Operating margin
-27.47%
Net margin
-444.23%
Return on equity
-171.29%
Return on assets
-92.79%
Return on invested capital
-7.68%

Financial health

Debt / equity
0.2×
Current ratio
1.01×
Altman Z-score
-18.5
Piotroski F-score
2 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends78%-74%-225%-377%Gross margin, FY2021: 27.00%Gross margin, FY2022: 39.67%Gross margin, FY2023: 23.32%Gross margin, FY2024: 21.00%Gross margin, FY2025: -13.51%Operating margin, FY2021: -211.61%Operating margin, FY2022: -141.38%Operating margin, FY2023: -66.19%Operating margin, FY2024: -26.29%Operating margin, FY2025: -26.80%Net margin, FY2021: -236.63%Net margin, FY2022: -156.93%Net margin, FY2023: -74.98%Net margin, FY2024: -26.73%Net margin, FY2025: -338.75%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 27.00%. Gross margin FY2022 39.67%. Gross margin FY2023 23.32%. Gross margin FY2024 21.00%. Gross margin FY2025 -13.51%. Operating margin FY2021 -211.61%. Operating margin FY2022 -141.38%. Operating margin FY2023 -66.19%. Operating margin FY2024 -26.29%. Operating margin FY2025 -26.80%. Net margin FY2021 -236.63%. Net margin FY2022 -156.93%. Net margin FY2023 -74.98%. Net margin FY2024 -26.73%. Net margin FY2025 -338.75%.

Income trends

Revenue

35.68M USD-40.05%

Operating income

−9.56M USD+38.88%

Net income

−120.85M USD-659.73%
Income trends across reported periods95.76M USD16.99M USD−61.77M USD−140.54M USDRevenue, FY2021: 8.98M USDRevenue, FY2022: 33.4M USDRevenue, FY2023: 76.07M USDRevenue, FY2024: 59.51M USDRevenue, FY2025: 35.68M USDOperating income, FY2021: −19M USDOperating income, FY2022: −47.22M USDOperating income, FY2023: −50.35M USDOperating income, FY2024: −15.65M USDOperating income, FY2025: −9.56M USDNet income, FY2021: −21.25M USDNet income, FY2022: −52.42M USDNet income, FY2023: −57.04M USDNet income, FY2024: −15.91M USDNet income, FY2025: −120.85M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 8.98M USD. Revenue FY2022 33.4M USD. Revenue FY2023 76.07M USD. Revenue FY2024 59.51M USD. Revenue FY2025 35.68M USD. Operating income FY2021 −19M USD. Operating income FY2022 −47.22M USD. Operating income FY2023 −50.35M USD. Operating income FY2024 −15.65M USD. Operating income FY2025 −9.56M USD. Net income FY2021 −21.25M USD. Net income FY2022 −52.42M USD. Net income FY2023 −57.04M USD. Net income FY2024 −15.91M USD. Net income FY2025 −120.85M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue35.68M USD59.51M USD76.07M USD33.4M USD8.98M USD
Cost of goods sold40.5M USD47.01M USD58.33M USD20.15M USD6.56M USD
Gross profit−4.82M USD12.5M USD17.74M USD13.25M USD2.43M USD
Research and development238K USD418K USD62K USD388K USD132K USD
Selling, general, and administrative1.21M USD23.08M USD23.34M USD28.78M USD17.76M USD
Operating expenses4.74M USD28.14M USD68.09M USD60.47M USD21.43M USD
Interest income29K USD
Interest expense199K USD213K USD92K USD32K USD
Depreciation and amortization582K USD768K USD2.34M USD2.63M USD501K USD
Operating income−9.56M USD−15.65M USD−50.35M USD−47.22M USD−19M USD
Net income−120.85M USD−15.91M USD−57.04M USD−52.42M USD−21.25M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
0%
0 beats, 11 misses, 0 met estimates
Average EPS surprise
-2226.31%
11 comparable reports
Latest EPS result
-2.47
Estimate -0.11 · Miss by 2145.45%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates-0.09-12.77-25.46-38.14Q1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Mar 24, 2025: actual -16.41, estimate -6.63, surprise -147.51%, Miss. Q2 2025, reported May 13, 2025: actual -1.56, estimate -0.39, surprise -300.00%, Miss. Q3 2025, reported Aug 1, 2025: actual -4.3, estimate -2.34, surprise -83.76%, Miss. Q4 2025, reported Nov 5, 2025: actual -4.93, estimate -2.13, surprise -131.46%, Miss. Q1 2026, reported Mar 23, 2026: actual -35.32, estimate -0.17, surprise -20725.47%, Miss. Q2 2026, reported May 4, 2026: actual -3.68, estimate -1.18, surprise -211.86%, Miss. Q3 2026, reported Jul 31, 2026: actual -2.47, estimate -0.11, surprise -2145.45%, Miss. Q4 2026, reported Nov 11, 2026: actual —, estimate -0.12, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates16.57M10.41M4.24M-1.93MQ1 '25MissQ2 '25MissQ3 '25BeatQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 24, 2025: actual 13.33M USD, estimate 13.5M USD, surprise -1.29%, Miss. Q2 2025, reported May 13, 2025: actual 11.79M USD, estimate 14.8M USD, surprise -20.36%, Miss. Q3 2025, reported Aug 1, 2025: actual 14.8M USD, estimate 11.8M USD, surprise +25.39%, Beat. Q4 2025, reported Nov 5, 2025: actual 9.75M USD, estimate 12.5M USD, surprise -22.02%, Miss. Q1 2026, reported Mar 23, 2026: actual -654K USD, estimate 15.3M USD, surprise -104.28%, Miss. Q2 2026, reported May 4, 2026: actual 7.27M USD, estimate 13.1M USD, surprise -44.47%, Miss. Q3 2026, reported Jul 31, 2026: actual 13.66M USD, estimate 7.3M USD, surprise +87.10%, Beat. Q4 2026, reported Nov 11, 2026: actual —, estimate 7.4M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$185

3827.81% upside
Past 12 months12-month forecastHigh $340Average $185Low $30.00

Rating distribution

6 ratings
Strong buy00%
Buy467%
Hold233%
Sell00%
Strong sell00%

Recent analyst actions

2 institutions
Alliance Global PartnersdowngradeBuyNeutral

ZSTK news

Corporate actions

Corporate action history

Stock split

Effective Aug 4, 2025

1:39

Stock split

Effective Jun 9, 2023

1:20

ZSTK peers

ETFs holding ZSTK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research ZSTK

research.disclaimer